CIK 0001971387 · <br>Emerging growth company
Liminatus Pharma, Inc.
Sign in to watch- Ticker
- LIMN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 213-273-5453
- Business address
- 12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
- Former names
- Iris Parent Holding Corp.
Securities
- LIMN Class A Common Stock Nasdaq
- LIMNW Warrants Nasdaq
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Delisting notice · Regulation FD disclosure
- 8-K Event Delisting notice · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 8-K Event Delisting notice · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Bylaws or fiscal year change
- PRE 14A Proxy Proxy Statement (Preliminary)
- S-1 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Other events
- 424B3 Offering Prospectus
Page 1 of 6 · 109 filings